The Charcot-Marie-Tooth Association (CMTA) has announced a $300,000 investment in a groundbreaking gene editing project aimed ...

Gene therapy pioneer Jim Wilson and researcher Kiran Musunuru are using contrasting approaches to overcome “irrational ...

The Series B funds will support the launch of a Phase I/II clinical trial for AIR-001 to advance its RNA editing pipeline.

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

CRISPR Therapeutics’ Julianne Bruno is hitting the exit in favor of external opportunities, marking the latest shakeup to the ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

In this article, I noted about the data that the company had released from its phase 1/2 study using in vivo CRISPR-based therapy NTLA-2002 for the treatment of patients with Hereditary Angioedema ...